Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2020
Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective studyDalong Yin, Changyong Ji, Shugeng Zhang, et al.
BMC Medical Imaging|November 25, 2021
A study of generalization and compatibility performance of 3D U-Net segmentation on multiple heterogeneous liver CT datasetsBaochun He, Dalong Yin, Xiaoxia Chen, et al.
BMC Cancer|October 27, 2014
FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signalingZhaoyang Lu, Jiabei Wang, Tongsen Zheng, et al.
Journal of Cellular Biochemistry|May 28, 2010
PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude miceTongsen Zheng, Xianzhi Meng, Jiabei Wang, et al.
Plos One|September 9, 2011
Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinomaYingjian Liang, Dalong Yin, Limin Hou, et al.
Molecular Cancer|October 8, 2013
LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathwayXuan Song, Jiabei Wang, Tongsen Zheng, et al.
Oncology Reports|October 27, 2015
Selecting molecular therapeutic drug targets based on the expression profiles of intrahepatic cholangiocarcinomas and miRNA-mRNA regulatory networksBoshi Sun, Changming Xie, Tongsen Zheng, et al.
Journal of Hepatology|March 20, 2026
IFRD1 orchestrates hepatocyte metabolism and macrophage interactions to facilitate liver regenerationTaofei Zeng, Yabin Huang, Hao He, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experienceShenyu Zhang, Guibin Yang, Ruipeng Song, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinomaYingjian Liang, Tongsen Zheng, Ruipeng Song, et al.
Pageof 6